Our Vision: Be a leader in
precision
technology
that powers
the future of
healthcare.

Learn About PHC Holdings Corporation
Integrated Report 2025

Integrated Report 2025

Online
PHC Group by the Numbers

PHC Group by the Numbers

Key facts and figures that demonstrate
our impact on health globally.

Learn More

Our Companies

Ascensia

Ascensia Diabetes Care is a global leader in diabetes technology. The company is entirely dedicated to improving the health and lives of people with diabetes, and provides solutions in more than 100 countries and regions.

Learn More

View Website

LSI Medience

LSI Medience contributes to the prevention, early detection, and treatment of disease through laboratory analysis in clinical testing. Its services include cancer diagnostics, genetic testing, and sports anti-doping testing.

Learn More

View Website

WEMEX

WEMEX is a healthcare solution provider that contributes to the digital transformation of healthcare in Japan. Its electronic medical record and electronic medication history systems support online insurance eligibility verification, electronic prescriptions, and integrations with services provided by other companies.

Learn More (Japanese website)

View Website

Mediford

Mediford offers services that support a wide range of research and development, from the exploratory phase of drug development to clinical testing, using reliable testing and analytical capabilities accumulated through extensive experience in contract research.

Learn More

View Website

Epredia

Epredia is a global leader at the heart of anatomical pathology labs, working to streamline the pathology workflow by providing a comprehensive range of solutions supporting precision cancer diagnostics. Every second of every day, 48 Epredia products are used in the battle against cancer.

Learn More

View Website

PHC

PHC Corporation develops, manufactures, and sells a variety of life sciences and diagnostic solutions. Our offerings include research and medical support equipment, such as ultra-low temperature freezers and CO2 incubators, plus innovative solutions for cell and gene therapy (CGT), including our live cell metabolic analyzer. Additionally, we provide testing and analysis devices, including point-of-care testing (POCT) equipment, and in vitro diagnostic reagents.

Learn More

View Website

ASCENSIA

LSI Meduence

Wemex

mediford

Epredia

PHC

The Potential of CAR-T Therapy in Cancer Treatment

Feature
The Potential of CAR-T Therapy in Cancer Treatment

PHC Group, in collaboration with the Centre for Commercialization of Regenerative Medicine (CCRM), hosted an online roundtable on the potential, challenges, and future outlook of CAR-T therapy in cancer treatment.

Learn More

image

PHC Group Virtual Showroom

Learn More

Our Products & Services